tiprankstipranks
Tryptamine Therapeutics Announces Director Departure
Company Announcements

Tryptamine Therapeutics Announces Director Departure

Tryptamine Therapeutics (AU:TYP) has released an update.

Don't Miss our Black Friday Offers:

Tryptamine Therapeutics has announced the departure of Peter Molloy from its board of directors, effective November 8, 2024. Molloy held a significant number of shares and options in the company, which are escrowed for 24 months. This change could impact investor sentiment as the company navigates its strategic direction without Molloy.

For further insights into AU:TYP stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App